Topic archive

psychedelic therapy

13 stories

10/7/2026

Ibogaine therapy shows promise for veterans with PTSD

Stanford study finds sustained PTSD relief in veterans a year after ibogaine treatment.

9/28/2026

Psyence BioMed and PsyLabs collaborate on ibogaine licensing agreement.

9/17/2026

Psychedelic therapies gain momentum as potential treatments for combat-related trauma.

8/26/2026

Ibogaine treatments in Mexico raise safety concerns for U.S. patients.

8/21/2026

David Dardashti shares clinical footage as psychedelic therapy gains federal interest.

8/19/2026

Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.

8/19/2026

Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.

8/18/2026

Governor's order initiates ibogaine, MDMA, and psilocybin study

7/31/2026

Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.

7/31/2026

Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.

7/23/2026

Order encourages psychedelic research, allocates $50M for state studies.

7/22/2026

Trump's 2026 executive order boosts psychedelic research funding and collaboration.

7/15/2026

New agreement includes ibogaine research for opioid use disorder.